| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 周豫 | 太平洋 | 医药生物 | 21.65% | 13.24% | 11.05% | 21.21% | 23 | -55.62% | 2025-06-06 |
| 2 | 华挺 | 财通证券 | 医药生物 | 21.64% | 16.72% | 14.74% | -6.67% | 4 | -50.33% | 2025-05-28 |
| 3 | 阳景 | 浦银国际证券 | 医药生物 | 21.64% | 24.10% | 17.39% | 100.00% | 3 | 0.00% | 2025-04-25 |
| 4 | 刘浩 | 华创证券 | 医药生物 | 21.63% | 42.12% | 12.24% | 29.41% | 2 | -47.33% | 2025-03-07 |
| 5 | 华挺 | 财通证券 | 医药生物 | 21.58% | 15.36% | 20.42% | -6.67% | 4 | -50.33% | 2025-05-13 |
| 6 | 胡博新 | 华鑫证券 | 医药生物 | 21.56% | 16.96% | 17.77% | -6.32% | 2 | -51.98% | 2025-06-16 |
| 7 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 21.53% | 46.39% | 13.15% | 9.68% | 1 | -27.10% | 2025-03-11 |
| 8 | 韩世通 | 中信证券 | 医药生物 | 21.52% | 15.56% | 7.32% | -2.04% | 4 | -63.25% | 2025-06-17 |
| 9 | 张静含 | 申万宏源 | 医药生物 | 21.51% | 18.68% | 16.66% | -13.64% | 4 | -54.88% | 2025-06-17 |
| 10 | 武煜 | 招银国际 | 医药生物 | 21.47% | 20.88% | 2.92% | -33.33% | 2 | -16.66% | 2025-06-23 |
| 11 | 周豫 | 太平洋 | 医药生物 | 21.45% | 19.16% | 9.14% | 21.21% | 23 | -55.62% | 2025-06-18 |
| 12 | 张静含 | 申万宏源 | 医药生物 | 21.43% | 18.73% | 15.78% | -13.64% | 4 | -54.88% | 2025-06-18 |
| 13 | 宋硕 | 中信证券 | 医药生物 | 21.36% | 10.59% | 13.85% | -10.64% | 3 | -47.62% | 2025-05-21 |
| 14 | 阳景 | 浦银国际证券 | 医药生物 | 21.33% | 14.55% | 14.63% | 100.00% | 4 | 0.00% | 2025-05-12 |
| 15 | 张静含 | 申万宏源 | 医药生物 | 21.32% | 13.95% | 17.48% | -13.64% | 4 | -54.88% | 2025-06-10 |
| 16 | 马云涛 | 国元证券 | 医药生物 | 21.28% | 13.07% | 19.69% | -17.65% | 3 | -47.07% | 2025-06-06 |
| 17 | 刘浩 | 华创证券 | 医药生物 | 21.26% | 36.12% | 14.97% | 29.41% | 2 | -47.33% | 2025-03-11 |
| 18 | 王斌 | 首创证券 | 医药生物 | 21.13% | 12.20% | 15.65% | 4.11% | 17 | -54.62% | 2025-06-09 |
| 19 | 夏禹 | 国联民生 | 医药生物 | 21.10% | 15.56% | 19.08% | 20.00% | 7 | -52.01% | 2025-05-13 |
| 20 | 华挺 | 财通证券 | 医药生物 | 21.10% | 17.78% | 18.92% | -6.67% | 4 | -50.33% | 2025-05-15 |